|
Journal of Lipid Research, Vol. 42, 799-812, May 2001
Copyright © 2001 by Lipid Research, Inc.
Sterols in blood of normal and Smith-Lemli-Opitz subjects
Benfang Ruanb,
William K. Wilsona,
Jihai Panga,
Nicolas Gersta,
Frederick D. Pinkertona,
James Tsaia,
Richard I. Kelleyc,
Frank G. Whitbyd,
Dianna M. Milewicze,
James Garbernf, and
George J. Schroepfer, Jr.a,b
a Department of Biochemistry and Cell Biology, Rice University, Houston, TX 77005
b Department of Chemistry, Rice University, Houston, TX 77005
c Kennedy Krieger Institute and Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205
d Department of Biochemistry, University of Utah, Salt Lake City, UT 84132
e Department of Internal Medicine, University of Texas-Houston Medical School, Houston, TX 77030
f Department of Neurology, Wayne State University, Detroit, MI 48201
Correspondence to:
William K. Wilson, To whom correspondence should be addressed., billw{at}rice.edu (E-mail)
Smith-Lemli-Opitz syndrome (SLOS) is a hereditary disorder in which a defective gene encoding 7-dehydrocholesterol reductase causes the accumulation of noncholesterol sterols, such as 7- and 8-dehydrocholesterol. Using rigorous analytical methods in conjunction with a large collection of authentic standards, we unequivocally identified numerous noncholesterol sterols in 6 normal and 17 SLOS blood samples. Plasma or erythrocytes were saponified under oxygen-free conditions, followed by multiple chromatographic separations. Individual sterols were identified and quantitated by high performance liquid chromatography (HPLC), Ag+-HPLC, gas chromatography (GC), GC-mass spectrometry, and nuclear magnetic resonance. As a percentage of total sterol content, the major C27 sterols observed in the SLOS blood samples were cholesterol (12;98%), 7-dehydrocholesterol (0.4;44%), 8-dehydrocholesterol (0.5;22%), and cholesta-5,7,9(11)-trien-3ß-ol (0.02;5%), whereas the normal blood samples contained <0.03% each of the three noncholesterol sterols. SLOS and normal blood contained similar amounts of lathosterol (0.05;0.6%) and cholestanol (0.1;0.4%) and 0.003;0.1% each of the 8, 8(14), 5,8(14), 5,24, 6,8, 6,8(14), and 7,24 sterols.
The results are consistent with the hypothesis that the 8(14) sterol is an intermediate of cholesterol synthesis and indicate the existence of undescribed aberrant pathways that may explain the formation of the 5,7,9(11) sterol. 19-Norcholesta-5,7,9-trien-3ß-ol was absent in both SLOS and normal blood, although it was routinely observed as a GC artifact in fractions containing 8-dehydrocholesterol. The overall findings advance the understanding of SLOS and provide a methodological model for studying other metabolic disorders of cholesterol synthesis. Ruan, B., W. K. Wilson, J. Pang, N. Gerst, F. D. Pinkerton, J. Tsai, R. I. Kelley, F. G. Whitby, D. M. Milewicz, J. Garbern, and G. J. Schroepfer, Jr. Sterols in blood of normal and Smith-Lemli-Opitz subjects. J. Lipid Res. 2001. 42: 799;812.
Supplementary key words:
SLOS, noncholesterol sterols, cholesta-5,8-dien-3ß-ol, Ag+-HPLC, NMR, GC-MS

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. B. Kodner, R. E. Summons, A. Pearson, N. King, and A. H. Knoll
Sterols in a unicellular relative of the metazoans
PNAS,
July 22, 2008;
105(29):
9897 - 9902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Wassif, K. E. Brownson, A. L. Sterner, A. Forlino, P. M. Zerfas, W. K. Wilson, M. F. Starost, and F. D. Porter
HEM dysplasia and ichthyosis are likely laminopathies and not due to 3{beta}-hydroxysterol {Delta}14-reductase deficiency
Hum. Mol. Genet.,
May 15, 2007;
16(10):
1176 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oostendorp, U. F.H. Engelke, M. A.A.P. Willemsen, and R. A. Wevers
Diagnosing Inborn Errors of Lipid Metabolism with Proton Nuclear Magnetic Resonance Spectroscopy
Clin. Chem.,
July 1, 2006;
52(7):
1395 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Pappu, R. D. Steiner, S. L. Connor, D. P. Flavell, D. S. Lin, L. Hatcher, D. R. Illingworth, and W. E. Connor
Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion
J. Lipid Res.,
October 1, 2002;
43(10):
1661 - 1669.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|